These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8254607)

  • 21. Structure of human PNP complexed with ligands.
    Canduri F; Silva RG; dos Santos DM; Palma MS; Basso LA; Santos DS; de Azevedo WF
    Acta Crystallogr D Biol Crystallogr; 2005 Jul; 61(Pt 7):856-62. PubMed ID: 15983407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pyrrolo[3,2-d]pyrimidines, a new class of purine nucleoside phosphorylase (PNP) inhibitors as potential T-cell selective immunosuppressive agents.
    Sircar JC; Kostlan CR; Gilbertsen RB; Dong MK; Cetenko WA
    Adv Exp Med Biol; 1991; 309A():45-8. PubMed ID: 1789265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The biochemical and pharmacological activity of 9-benzyl-9-deazaguanine, a potent purine nucleoside phosphorylase (PNP) inhibitor.
    Kimble E; Hadala J; Ludewig R; Peters P; Greenberg G; Xiao G; Guida W; McQuire L; Simon P
    Inflamm Res; 1995 Aug; 44 Suppl 2():S181-2. PubMed ID: 8548387
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparative in vitro and in vivo activities of two 9-deazaguanine analog inhibitors of purine nucleoside phosphorylase, CI-972 and PD 141955.
    Gilbertsen RB; Josyula U; Sircar JC; Dong MK; Wu WS; Wilburn DJ; Conroy MC
    Biochem Pharmacol; 1992 Sep; 44(5):996-9. PubMed ID: 1530667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitors of human purine nucleoside phosphorylase. Synthesis, purine nucleoside phosphorylase inhibition, and T-cell cytotoxicity of 2,5-diaminothiazolo[5,4-d]pyrimidin-7(6H)-one and 2,5-diaminothiazolo[4,5-d]pyrimidin-7(6H)-one. Two thio isosteres of 8-aminoguanine.
    Sircar JC; Suto MJ; Scott ME; Dong MK; Gilbertsen RB
    J Med Chem; 1986 Sep; 29(9):1804-6. PubMed ID: 3091835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transition state structure of purine nucleoside phosphorylase and principles of atomic motion in enzymatic catalysis.
    Fedorov A; Shi W; Kicska G; Fedorov E; Tyler PC; Furneaux RH; Hanson JC; Gainsford GJ; Larese JZ; Schramm VL; Almo SC
    Biochemistry; 2001 Jan; 40(4):853-60. PubMed ID: 11170405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purine nucleoside phosphorylase. 1. Structure-function studies.
    Erion MD; Takabayashi K; Smith HB; Kessi J; Wagner S; Hönger S; Shames SL; Ealick SE
    Biochemistry; 1997 Sep; 36(39):11725-34. PubMed ID: 9305962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crystal structure of human PNP complexed with guanine.
    de Azevedo WF; Canduri F; dos Santos DM; Pereira JH; Bertacine Dias MV; Silva RG; Mendes MA; Basso LA; Palma MS; Santos DS
    Biochem Biophys Res Commun; 2003 Dec; 312(3):767-72. PubMed ID: 14680831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crystal structure and molecular dynamics studies of human purine nucleoside phosphorylase complexed with 7-deazaguanine.
    Caceres RA; Timmers LF; Pauli I; Gava LM; Ducati RG; Basso LA; Santos DS; de Azevedo WF
    J Struct Biol; 2010 Mar; 169(3):379-88. PubMed ID: 19932753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 9-Deazaguanine derivatives connected by a linker to difluoromethylene phosphonic acid are slow-binding picomolar inhibitors of trimeric purine nucleoside phosphorylase.
    Breer K; Glavas-Obrovac L; Suver M; Hikishima S; Hashimoto M; Yokomatsu T; Wielgus-Kutrowska B; Magnowska L; Bzowska A
    FEBS J; 2010 Apr; 277(7):1747-60. PubMed ID: 20193043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Purine nucleoside phosphorylase. 2. Catalytic mechanism.
    Erion MD; Stoeckler JD; Guida WC; Walter RL; Ealick SE
    Biochemistry; 1997 Sep; 36(39):11735-48. PubMed ID: 9305963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel multisubstrate inhibitors of mammalian purine nucleoside phosphorylase.
    Toms AV; Wang W; Li Y; Ganem B; Ealick SE
    Acta Crystallogr D Biol Crystallogr; 2005 Nov; 61(Pt 11):1449-58. PubMed ID: 16239721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and biological activity of a novel class of purine nucleoside phosphorylase inhibitors.
    Morris PE; Elliott AJ; Walton SP; Williams CH; Montgomery JA
    Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):379-404. PubMed ID: 10772722
    [No Abstract]   [Full Text] [Related]  

  • 34. Open and closed conformation of the E. coli purine nucleoside phosphorylase active center and implications for the catalytic mechanism.
    Koellner G; Bzowska A; Wielgus-Kutrowska B; Luić M; Steiner T; Saenger W; Stepiński J
    J Mol Biol; 2002 Jan; 315(3):351-71. PubMed ID: 11786017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Guanine, pyrazolo[3,4-d]pyrimidine, and triazolo[4,5-d]pyrimidine (8-azaguanine) phosphonate acyclic derivatives as inhibitors of purine nucleoside phosphorylase.
    Beauchamp LM; Tuttle JV; Rodriguez ME; Sznaidman ML
    J Med Chem; 1996 Feb; 39(4):949-56. PubMed ID: 8632418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of crystallographic and modeling methods in the design of purine nucleoside phosphorylase inhibitors.
    Ealick SE; Babu YS; Bugg CE; Erion MD; Guida WC; Montgomery JA; Secrist JA
    Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11540-4. PubMed ID: 1763067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitors of human purine nucleoside phosphorylase. Synthesis of pyrrolo[3,2-d]pyrimidines, a new class of purine nucleoside phosphorylase inhibitors as potentially T-cell selective immunosuppressive agents. Description of 2,6-diamino-3,5-dihydro-7-(3-thienylmethyl)-4H-pyrrolo[3,2-d] pyrimidin-4-one.
    Sircar JC; Kostlan CR; Gilbertsen RB; Bennett MK; Dong MK; Cetenko WJ
    J Med Chem; 1992 May; 35(9):1605-9. PubMed ID: 1578487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PD 141955 and CI-972: 9-deazaguanine analog purine nucleoside phosphorylase inhibitors. II. Effects on nucleoside catabolism in human and rat blood in vitro.
    Dong MK; Gilbertsen RB
    Agents Actions; 1993; 39 Spec No():C99-101. PubMed ID: 8273600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-activity relationships for a class of inhibitors of purine nucleoside phosphorylase.
    Farutin V; Masterson L; Andricopulo AD; Cheng J; Riley B; Hakimi R; Frazer JW; Cordes EH
    J Med Chem; 1999 Jul; 42(13):2422-31. PubMed ID: 10395483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simplified analogues of immucillin-G retain potent human purine nucleoside phosphorylase inhibitory activity.
    Semeraro T; Lossani A; Botta M; Ghiron C; Alvarez R; Manetti F; Mugnaini C; Valensin S; Focher F; Corelli F
    J Med Chem; 2006 Oct; 49(20):6037-45. PubMed ID: 17004717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.